Forecast & Rating2 analysts currently cover BIOKIN PHARMACEUTICAL, of which 2 give a positive rating. The average price target is ¥336.12, about 37.4% upside from the current price of ¥244.58. Coverage is limited, so the data is for reference only. Data as of Aug 28, 2026; this does not constitute investment advice.
Aug 28, 2026Price forecast
¥336.1237.43%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 13, 2026
Forecast met85.8%
Stock price$244.58
Avg. target$336.1
High target$336
Low target$336
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.